Study guide
9.1 Anti-Infectives & Infection Management
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
9.1 Anti-Infectives & Infection Management
Key Takeaways Explain This Topic AI
Community anti-infective decisions rest on indication, likely pathogen, allergy history (true allergy vs intolerance), renal function, interactions, and a defined duration — not ‘finish the box’ as a substitute for clinical sense.
Beta-lactam cross-reactivity is nuanced: many patients labelled penicillin-allergic can safely use selected cephalosporins when the history is non-severe and side-chains differ, but anaphylaxis or severe cutaneous reactions demand specialist-safe pathways.
C. difficile risk rises with broad-spectrum agents, prolonged courses, and age/comorbidity; counsel diarrhoea red flags and stewardship restraint for viral presentations.
Oseltamivir is time-critical (ideally within 48 hours of influenza symptom onset in indicated groups); fluconazole has important CYP interactions (e.g. warfarin, some statins) that require active check.
Intern Written items reward matching drug class to common community syndromes (UTI, cellulitis, otitis) and withholding antibiotics when self-limiting viral illness is the better explanation.
Last updated: August 2026
9.1 Anti-Infectives & Infection Management
Quick Answer: For community infection scenarios, confirm a bacterial indication (or other clear anti-infective need), check allergy quality and cross-reactivity risk, match an appropriate spectrum and duration, screen renal function and interactions, counsel adherence and red flags, and practise stewardship — especially avoiding antibiotics for typical viral upper respiratory illness. Use AMH for dosing, cautions, and duration; use APF for counselling standards.
Anti-infectives appear across APC Intern Written competencies 3.1–3.3 : assess the clinical situation, implement a medication plan, and monitor for efficacy, adverse effects, and resistance-related harm. This section focuses on community-facing agents and syndromes you will see at the counter and in primary-care prescriptions — not full hospital ID specialty practice.
Stewardship first — then drug selection
Australian quality use of medicines expects judicious antimicrobial use : right patient, right drug, right dose, right duration, and no drug when none is needed. Stewardship in community pharmacy includes:
Explaining that many colds, flu-like illnesses, and acute bronchitis are viral and do not improve with antibiotics
Supporting symptomatic care and safety-netting (worsening dyspnoea, dehydration, high fever, confusion, chest pain)
- Checking that prescribed courses have a plausible indication and duration
- Flagging duplicate anti-infectives, unnecessary prolonged courses, and interactions
- Encouraging return if diarrhoea is severe or persistent (possible Clostridioides difficile )
Intern exam answers that automatically “start an antibiotic” for a self-limiting viral picture are usually wrong. Answers that match spectrum to syndrome and define stop rules are usually right.
- Common community antibiotic classes
- Penicillins
Phenoxymethylpenicillin (penicillin V) and amoxicillin remain first-line for many streptococcal and susceptible respiratory or ENT pathogens when allergy does not preclude them. Amoxicillin with clavulanic acid broadens coverage against beta-lactamase-producing organisms (e.g. some skin/soft-tissue or mixed infections) but increases gastrointestinal adverse effects and C. difficile risk relative to narrower agents.
Counselling priorities: complete the prescribed course unless advised to stop for toxicity; take with or without food as product-specific (clavulanate combinations often better tolerated with food); report rash, swelling, or breathing difficulty promptly.
Cephalosporins
Oral cefalexin is widely used for skin and soft-tissue infection and selected urinary tract infection (UTI) contexts per guidelines. Spectrum and generation matter: broader cephalosporins are not automatically “stronger and better” for community syndromes and may worsen resistance and C. difficile ecology.
Macrolides
Azithromycin , clarithromycin , and erythromycin are alternatives in penicillin allergy for some indications, and cover atypical respiratory pathogens in selected pneumonia pathways. Watch QT prolongation risk (especially with interacting drugs), CYP3A4 interactions (clarithromycin is a notable inhibitor), and gastrointestinal intolerance. Clarithromycin–statin interactions can precipitate myopathy — check before supply.
Tetracyclines
Doxycycline is common for selected respiratory, skin, and other community indications. Counsel: photosensitivity, oesophagitis risk (take with adequate water, remain upright), and avoid concurrent antacids/iron/calcium that chelate absorption. Not for pregnancy or young children when alternatives exist (tooth staining / developmental concerns — follow AMH age rules).
Trimethoprim and nitrofurantoin
Trimethoprim is a classic short-course agent for uncomplicated lower UTI in many Australian primary-care pathways when resistance patterns allow. Nitrofurantoin is highly concentrated in urine and used for lower UTI; it is not appropriate for pyelonephritis or systemic infection because tissue levels are inadequate. Check renal function for nitrofurantoin — efficacy falls and toxicity risk rises when eGFR is low (confirm current AMH cut-offs). Counsel brown urine with nitrofurantoin and complete short courses as directed.
Class / agent Typical community roles (high-level) Key counselling / safety
Amoxicillin ± clavulanate ENT, respiratory, skin (broader with clavulanate) Diarrhoea, allergy, C. diff risk with broader use
- Cefalexin Skin/soft tissue; selected UTI Allergy cross-reactivity principles
- Macrolides Penicillin-allergy alternatives; atypical cover QT, CYP interactions, GI upset
- Doxycycline Selected respiratory/skin and other uses Photosensitivity, oesophagitis, chelation
- Trimethoprim Uncomplicated lower UTI (when appropriate) Resistance, pregnancy cautions per AMH
- Nitrofurantoin Uncomplicated lower UTI only Renal function; not for pyelonephritis
- Allergy and cross-reactivity principles
“Penicillin allergy” on the record is often intolerance (nausea, thrush, mild delayed rash decades ago) rather than IgE-mediated anaphylaxis. Poor documentation drives unnecessary broad-spectrum use.
Exam-ready principles:
Clarify the reaction — timing, severity, organ involvement, treatment needed, and whether the patient later tolerated related drugs.
True immediate allergy (urticaria, angioedema, anaphylaxis soon after a dose) is high risk for re-exposure to the same drug and close relatives.
Severe delayed reactions (e.g. severe cutaneous adverse reactions, organ involvement) generally mean avoid related beta-lactams pending specialist advice.
Cross-reactivity between penicillins and cephalosporins is not automatic . Risk is higher with similar R1 side-chains; many non-severe histories allow carefully selected cephalosporins. Do not invent “always cross-reacts” or “never cross-reacts” absolute rules — use history quality + AMH/specialist guidance.
If the history is unclear and the indication is non-urgent, defer and clarify rather than default to an unnecessarily broad second-line agent without reason.
Document what you clarified. Intern scenarios often reward reclassifying a vague childhood rash before cascading to last-line options.
Syndrome duration concepts (high-level)
Exact durations change with guidelines and local resistance — always verify AMH/therapeutic guidelines for the exam open-book context. Master duration logic , not memorised trivia alone:
Syndrome (community) Duration concept Pharmacist focus
Uncomplicated lower UTI (non-pregnant adults, typical pathways) Short courses often preferred when agent and susceptibility fit Nitrofurantoin/trimethoprim role; red flags for pyelonephritis (fever, flank pain, systemic illness)
Cellulitis Often longer than simple UTI courses; ensure adequate coverage and review Mark progress; escalate if spreading rapidly, systemic toxicity, or facial/orbital involvement
Acute otitis media Many children improve with observation/symptomatic care; antibiotics when indicated are time-limited Analgesia first; age, severity, and bilateral disease influence antibiotic decisions
Do not extend antibiotics “just in case” without clinical reason. Do counsel that improvement should begin within a few days for many bacterial infections — lack of improvement needs medical review, not automatic second scripts at the counter without assessment.
Clostridioides difficile risk
Almost any antibiotic can precipitate C. difficile infection (CDI), but risk is higher with broad-spectrum agents, prolonged or repeated courses, hospital exposure, advanced age, and proton pump inhibitor co-use. Community pharmacists should:
Prefer narrower effective agents when prescribed choices allow stewardship discussion with the prescriber
Counsel patients to seek urgent review for profuse watery diarrhoea, severe abdominal pain, fever, or blood in stool during or after antibiotics
- Avoid antidiarrhoeal self-medication that masks severe colitis when CDI is possible
- Support hand hygiene and careful antibiotic indication review in recurrent CDI history
CDI is a stewardship and safety outcome, not merely an inconvenience.
- Select antifungals and antivirals — counselling high points
- Fluconazole
Oral fluconazole is used for selected candida infections (e.g. vaginal candidiasis single-dose pathways when appropriate). Interaction check is mandatory: fluconazole inhibits CYP pathways and can potentiate warfarin (INR rise), interact with some statins , and affect other narrow-therapeutic-index drugs. Confirm concurrent medicines before supply, including OTC and complementary products. Counsel expected response time and when thrush-like symptoms need medical review (recurrent, pregnancy, diabetes, immunosuppression).
Oseltamivir
Oseltamivir for influenza is time-critical . Benefit is greatest when started as early as possible , ideally within 48 hours of symptom onset , in people for whom treatment is indicated (high-risk groups, severe disease pathways — follow current national guidance). Late initiation still occurs in some severe or high-risk settings under clinician direction, but “start anytime for mild illness days later” is not a general community rule. Counsel: full course as directed, gastrointestinal adverse effects, and that antivirals are not a substitute for influenza vaccination. Check renal dosing adjustments in AMH.
Other antifungals (high-level)
Topical azoles for skin/vaginal use need correct duration and site counselling. Oral terbinafine (when prescribed for nail/skin infection) requires interaction and hepatic caution awareness. Systemic antifungals beyond community single-dose candidiasis usually need more structured monitoring — escalate uncertainty.
Monitoring and when to escalate
During and after anti-infective supply:
Efficacy — symptom trajectory matches expected infection course
Toxicity — rash, anaphylaxis symptoms, severe diarrhoea, tendon symptoms with fluoroquinolones if used, photosensitivity with doxycycline
- Interactions — macrolides, fluconazole, rifamycins (when present) with chronic medicines
- Adherence barriers — taste, cost, complex multi-daily dosing, side effects leading to early stop
Red flags requiring urgent medical care: sepsis features (fever with rigors, confusion, hypotension symptoms), rapidly progressive cellulitis, suspected pyelonephritis, respiratory distress, or anaphylaxis.
Exam mindset
Intern Written anti-infective items rarely reward “strongest antibiotic available.” They reward indication clarity , allergy quality , spectrum matching , duration discipline , interaction checks , and stewardship communication . When AMH is open, use it for the exact dose and caution — your clinical reasoning still chooses the safe pathway.